Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2Hot Flashes 1Breast Neoplasms 1

Interventions

Acupuncture Therapy 10Gabapentin 7Venlafaxine Hydrochloride 5Isoflavones 3Bupivacaine 3black cohosh root extract 2Tamoxifen 2Soybean Proteins 2Sodium Chloride 2Magnesium Oxide 2Control Groups 2Citalopram 2oxybutynin 1liposomal amphotericin B 1fezolinetant 1bazedoxifene 1Zolpidem 1Vitamin B 6 1Therapeutics 1Testosterone 1Tablets 1Sugars 1Solifenacin Succinate 1Sertraline 1Pregabalin 1Mindfulness-Based Stress Reduction 1Mindfulness 1Mind-Body Therapies 1Linseed Oil 1Hypnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hot Flashes × Estetrol × Clear all
NCT03361969 2021-06-18

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Pantarhei Oncology B.V.

Phase 2 Completed
63 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡